Exelixis Inc reports results for the quarter ended December 31 - Earnings Summary

Exelixis

11/02/2025 22:49

* Exelixis Inc  EXEL.OQ  reported quarterly adjusted
earnings of
48 cents​​ per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of 27 cents.  The mean expectation of twenty three analysts for
the quarter was for earnings of 43 cents per share. Wall Street
expected results to range from 16 cents to 56 cents per share.
    * Revenue rose 18.2% to $566.76 million from a year ago;
analysts
expected $563.42 million. 
    * Exelixis Inc's reported EPS for the quarter was 48 cents​.
    * The company reported quarterly net income of $139.86
million.
    * Exelixis Inc shares had risen by 0.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 9
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is
$37.50 
This summary was machine generated from LSEG data February 11 at
10:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.43           0.48           Beat
 Sep. 30 2024      0.35           0.40           Beat
 Jun. 30 2024      0.30           0.77           Beat
 Mar. 31 2024      0.24           0.20           Missed